MIB Startup Studio launches its first call for applications to support immunology startups
Marseille, 6 July 2026 – Marseille Immunology Biocluster has launched the first call for applications for MIB Startup Studio, an initiative designed to support immunology startups in their scientific, strategic and entrepreneurial development.
Created to support high-potential projects, MIB Startup Studio is aimed at established startups seeking to accelerate their development by connecting with a leading scientific, clinical, technological, industrial and financial ecosystem.
Through this programme, MIB is pursuing a clear ambition: to help transform scientific discoveries into tangible therapeutic innovations that can reach patients and create long-term value.
Supporting immunology startups at key stages of their development
Developing a biotech startup involves numerous challenges, including consolidating its scientific strategy, accessing regulatory and clinical expertise, structuring its business model, identifying industry partners, preparing for fundraising and gaining access to technology platforms.
MIB Startup Studio was designed to support startups through these critical stages by drawing on the expertise of Marseille’s and France’s ecosystems in immunology, immunotherapies and translational medicine.
Connecting science, clinical practice, industry and investment
Based in Marseille, MIB brings together academic, hospital, industry and institutional stakeholders around a shared ambition: accelerating innovation in immunology.
Through this first call for applications, MIB Startup Studio aims to foster synergies between researchers, entrepreneurs, clinicians, investors and industry partners in order to support the development of innovative therapeutic solutions.
Apply for the first call for applications
Interested startups are invited to visit the dedicated page to learn more about the programme, eligibility criteria, timeline and application process.
Partager
Actualités